Founding partner of Pharmspective, LLC, a Specialty Therapeutics Market Research firm providing commercial insights and knowledge management applications for the biopharmaceutical industry. http://www.pharmspective.com/

Key member of boutique life sciences consulting firm. Successfully led a wide range of strategic engagements including: commercialization plans; brand plans; licensing & acquisition opportunity assessments; franchise strategies; quantitative “patient flow” projects; pricing projects and market opportunity assessments for a wide range of biopharmaceutical clients. Directed both primary and secondary research.

Led a wide range engagements for biotechnology and diagnostic companies including: licensing & acquisition opportunity assessments; R&D prioritization projects and market opportunity assessments. Many of these projects were highly technical requiring strong knowledge of drug discovery technologies and other biotechnology platforms.

Researched genomics and proteomics of breast cancer in collaboration with the Dana Farber Cancer Institute and the Whitehead Institute at MIT. Published research papers and presented posters at national meetings on breast cancer and pancreatic cancer.

Completed internship year in comprehensive general surgery training program with rotations in cardio-thoracic and thoracic, colorectal, surgical ICU, vascular, breast and trauma, among others.

Performed financial analysis in support of mergers and acquisitions, privatization advisory services, corporate financial advisory services, public debt offerings and equity offerings for domestic and foreign electric utilities and independent power producers.